Impaired fibrinolysis in patients with Blackfoot disease.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Thrombosis Research

• Publication date

  1993-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0049-3848(93)90188-TPMID 8303660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells.

  1992cited by this paper
• Plasminogen Activators t-PA, u-PA and Its Inhibitor (PAI) in Normal Males and Females

  1991cited by this paper
• Regulation of type I plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells.

  1991cited by this paper
• Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.

  1990cited by this paper
• Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour.

  1990cited by this paper
• Zinc supplementation during diarrhoea, a fortification against malnutrition?

  1990cited by this paper
• A possible pathogenesis for Blackfoot disease--effects of trivalent arsenic (As2O3) on cultured human umbilical vein endothelial cells.

  1990cited by this paper
• A Possible Pathogenesis for Blackfoot Disease

  1990cited by this paper
• Tissue-plasminogen activator stimulates endothelial cell migration in wound assays.

  1990cited by this paper
• Blackfoot disease.

  1990cited by this paper
• Impaired fibrinolysis in patients with thrombotic or haemostatic defects.

  1989cited by this paper
• Plasma levels of t-PA free PAI-1 and a complex of t-PA with PAI-1 in human males and females at various ages.

  1989cited by this paper
• Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells.

  1988cited by this paper
• Atherogenicity and Carcinogenicity of High‐Arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease

  1988cited by this paper
• Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus

  1988cited by this paper
• Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.

  1988cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Activation of Plasminogen by Pro-urokinase

  1986cited by this paper
• Activation of plasminogen by pro-urokinase. I. Mechanism.

  1986cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• The role of the fibrinolytic system in deep vein thrombosis.

  1985cited by this paper
• Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers.

  1985cited by this paper
• Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

  1984cited by this paper
• Tissue Plasminogen Activator: Chemical and Physiological Aspects

  1984cited by this paper
• Increased circulating platelet aggregates and coagulation factors in patients with Blackfoot disease.

  1983cited by this paper
• Factor VIII/von Willebrand factor.

  1983cited by this paper
• Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.

  1982cited by this paper
• [Outcome of patients with blackfoot disease].

  1975cited by this paper
• Outcome of patients with blackfoot disease

  1975cited by this paper
• The natural history of blackfoot disease.

  1973cited by this paper
• Epidemiologic studies on blackfoot disease in Taiwan, China. 6. Effect of the piped water supply on occurrence and disease progress of blackfoot disease.

  1969cited by this paper
• Epidemiologic studies on blackfoot disease. 2. A study of source of drinking water in relation to the disease.

  1962cited by this paper

• Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells

  2021cites this paper
• Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study

  2017cites this paper
• The Novel Role of Fenofibrate in Preventing Nicotine- and Sodium Arsenite-Induced Vascular Endothelial Dysfunction in the Rat

  2010cites this paper
• Arsenic Exposure and Cardiovascular Disorders: An Overview

  2009cites this paper
• Mechanisms for Arsenic-Stimulated Sinusoidal Endothelial Cell Capillarization

  2008cites this paper
• Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice

  2007influential citation
• Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.

  2007cites this paper
• Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.

  2004cites this paper
• Decrease of fibrinolytic activity in human endothelial cells by arsenite.

  2002cites this paper
• Arsenic and atherosclerosis.

  2000cites this paper
• Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.

  1999cites this paper
• Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways.

  1999cites this paper
• Myeloproliferative and metabolic causes.

  1994cites this paper
• 10 Myeloproliferative and metabolic causes

  1994cites this paper
• American Journal of Epidemiology Original Contribution Association between Arsenic Exposure from Drinking Water and Plasma Levels of Cardiovascular Markers

  year unknowncites this paper